Ventana President Mara Aspinall: An Interview With “The Pink Sheet” DAILY
By
Jessica Merrill / Email the Author / “The Pink Sheet” DAILY Jan. 19, 2012
Word Count: 2020 / Article # 14120119003
Executive Summary
In the midst of a busy January – in which Ventana has signed four publicly disclosed deals to develop companion diagnostics with pharma partners – Ventana President Mara Aspinall talked with “The Pink Sheet” DAILY about pharma’s evolving attitude on personalized medicine, sharing value for joint projects and how Ventana is positioning itself to be the partner of choice for pharma.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.